Debevoise & Plimpton LLP
Fried, Frank, Harris, Shriver & Jacobson LLP
Mark is an accomplished and versatile corporate and transactional attorney in the life sciences industry, providing his clients with over 25 years of experience. His background includes advising, structuring, drafting and negotiating strategic transactions at all stages of the product lifecycle - from research and development through commercialization.
Mark began his career as an attorney at a top tier international law firm in New York focusing on M&A, securities law and structured finance transactions. He then spent over 17 years in-house at Pfizer, where he handled several high profile business transactions; advised C-suite executives and senior leadership teams for Pfizer’s R&D organization; and led a team of attorneys focused on advising, structuring, drafting and negotiating sophisticated and complex life sciences transactions for over a decade.
Mark has a firm working grasp of the science behind emerging technologies and product modalities, including RNAi, cell therapy and gene therapy. This combined with Mark’s broad transactional experience and acute sensitivity to the business dynamics driving the deal enables him to translate complex scientific and IP concepts into practical business solutions for his clients.
Mark teaches the contracting section for the Business Development course at BIO’s annual international convention and is a frequent panelist at other industry meetings and seminars.
Vice President and Assistant General Counsel